Richa Manwani
Rowland Hill Street
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
EPR25-117: Cardiovascular Events in Patients Diagnosed With Light Chain Amyloidosis in the USA: A Real-World Analysis Utilizing Electronic Health Records.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 28, 2025
Incidence and prevalence of light chain amyloidosis in the United States in 2019-2021 using Optum EHR data.
Journal: Scientific reports
Published: February 07, 2025
Phase I/II results of ceralasertib as monotherapy or in combination with acalabrutinib in high-risk relapsed/refractory chronic lymphocytic leukemia.
Journal: Therapeutic advances in hematology
Published: October 25, 2022
Linking changes in quality of life to haematologic response and survival in systemic immunoglobulin light-chain amyloidosis.
Journal: British journal of haematology
Published: August 24, 2022
Prognostic importance of the 6 min walk test in light chain (AL) amyloidosis.
Journal: Heart (British Cardiac Society)
Published: December 17, 2021
Autologous stem cell transplantation vs bortezomib based chemotheraphy for the first-line treatment of systemic light chain amyloidosis in the UK.
Journal: European journal of haematology
Published: October 26, 2020
Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis.
Journal: European heart journal
Published: October 21, 2020
99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis.
Journal: European heart journal. Cardiovascular Imaging
Published: September 02, 2020
Amyloidosis Diagnosed in Solid Organ Transplant Recipients.
Journal: Transplantation
Published: February 01, 2020
Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis.
Journal: Circulation
Published: May 22, 2019
Last Updated: 09/26/2026